← Eichor
Condition: Symptomatic Obstructive Hypertrophic Cardiomyopathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Symptomatic Obstructive Hypertrophic Cardiomyopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
Phase 4 · 4 location(s) · Morten Steen Kvistholm Jensen · NCT05569382A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Phase N/A · 2 location(s) · Bristol-Myers Squibb · NCT06146660A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · 99 location(s) · Bristol-Myers Squibb · NCT05489705A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic
Phase 3 · 108 location(s) · Lexicon Pharmaceuticals · NCT06481891Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07150299A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopat
Phase 2/Phase 3 · 38 location(s) · Cytokinetics · NCT06412666A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic C
Phase 2 · 67 location(s) · Imbria Pharmaceuticals, Inc. · NCT07023614Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MY
Phase 1/Phase 2 · 10 location(s) · Tenaya Therapeutics · NCT05836259
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.